Exhaled breath acetone for predicting cardiac and overall mortality in chronic heart failure patients

AIMS: Exhaled breath acetone (EBA) has been described as a new biomarker of heart failure (HF) diagnosis. EBA concentration increases according to severity of HF and is associated with poor prognosis, especially in acute decompensated HF. However, there are no data on chronic HF patients. The aim is...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ESC Heart Fail
Hlavní autoři: Marcondes‐Braga, Fabiana G., Gioli‐Pereira, Luciana, Bernardez‐Pereira, Sabrina, Batista, Guilherme L., Mangini, Sandrigo, Issa, Victor S., Fernandes, Fabio, Bocchi, Edimar A., Ayub‐Ferreira, Silvia M., Mansur, Alfredo J., Gutz, Ivano G.R., Krieger, Jose E., Pereira, Alexandre C., Bacal, Fernando
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2020
Témata:
Original Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373929/
https://ncbi.nlm.nih.gov/pubmed/32383349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12736
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky